Suppression of the tumorigenicity of prostatic cancer cells by gene(s) located on human chromosome 19p13.1-13.2

Prostate

Volumn 38, Issue 1, 1999, Pages 46-54

  Gao, Allen C ^a   Lou, Wei ^a   Ichikawa, Tomohiko ^b   Denmeade, Samuel R ^a   Barrett, Carl ^c   Isaacs, John T ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHIBA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Chromosome 19; Prostate; Tumor suppression

Indexed keywords

ANTIGEN SPECIFICITY; ARTICLE; CANCER CELL; CANCER GROWTH; CHROMOSOMAL LOCALIZATION; CHROMOSOME 19P; CHROMOSOME ANALYSIS; CLONOGENIC ASSAY; GENE LOCATION; GENE MAPPING; HUMAN; HUMAN CELL; KARYOTYPE; MOLECULAR CLONING; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE;

ANIMALS; BLOTTING, NORTHERN; CARCINOGENICITY TESTS; CHROMOSOMES, HUMAN, PAIR 19; DNA PROBES; GENES, TUMOR SUPPRESSOR; HUMANS; HYBRID CELLS; KARYOTYPING; MALE; MICE; MICE, NUDE; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RATS; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0032893067     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990101)38:1<46::AID-PROS6>3.0.CO;2-9     Document Type: Article

References (33)

1. Rinker-Schaeffer C, Partin AW, Isaacs WB, Coffey DS, Isaacs JT. Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells. Prostate 1994;25: 249-265.
2. Ichikawa T, Ichikawa Y, Dong JT, Hawkins AL, Griffin CA, Isaacs WB, Oshimura M, Barrett CJ, Isaacs JT. Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res 1992;52:3486-3490.
3. Ichikawa T, Nihei N, Suzuki H, Mitsuo O, Mitsuru E, Nakamura Y, Hayata I, Isaacs JT, Shimazaki J. Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8. Cancer Res 1994;54:2299-2302.
4. Nihei N, Ichikawa T, Kawana Y, Kuramochi H, Kugo H, Oshimura M, Killary AM, Rinker-Schaeffer CW, Barrett JC, Isaacs JT, Shimazaki J. Localization of metastasis suppressor gene(s) for rat prostatic cancer to the long arm of human chromosome 10. Genes Chromosomes Cancer 1995;14:112-119.
5. Rinker-Schaeffer CW, Hawkins AL, Ru N, Dong JT, Stoice G, Griffin C, Ichikawa T, Barrett JC, Isaacs JT. Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res 1994;54:6249-6256.
6. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995;268:884-886.
7. Gao AC, Lou W, Dong JT, Isaacs JT. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res 1997;57:846-849.
8. Genome Data Base (GDB™). "The Human Genome Data Base Project." Baltimore: Johns Hopkins University. World Wide Web URL: http://gdbwww.gdb.org/gdbdoc/topq.html, data as of October 15, 1996.
9. Riegman PHJ, Vlietstra RJ, Suurmeijer L, Cleutjens CBJM, Trapman J. Characterization of the human kallikrein locus. Genomics 1992;14:6-11.
10. Durocher F, Morissette J, Dufort I, Simard J, Luu-The V. Genetic linkage mapping of the dehydroepiandrosterone sulfotransferase (STD) gene on the chromosome 19q13.3 region. Genomics 1995;29:781-783.
11. Aslanidis C. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 1992;355:548-551.
12. Joutel A, Bousser MG, Biousse V, Labauge P, Chabriat H, Nibbio A, Maciazek J, Meyer B, Bach MA, Weissenbach J, Lathrop GM, Tournier-Lasserve E. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 1993;5:40-45.
13. Strittmatter WJ, Snaunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvensen GS, Roses AD. Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci USA 1995;92:4725-4727.
14. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 1996;56:3091-3102.
15. Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, Qian J, Takahashi S, Jenkins RB, Bostwick DG, Thibodeau SN. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res 1996;56:4475-4482.
16. Kleinerman DI, Troncoso P, Lin SH, Pisters LL, Sherwood ER, Brooks T, von Eschenbach AC, Hsieh JT. Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: Implication as a tumor suppressor. Cancer Res 1995;55:1215-1220.
17. Ilzumi T, Yazaki T, Kanoh S, Kondo I, Koiso K. Establishment of a new prostatic carcinoma cell line (TSU-PR1). J Urol 1987;137: 1304-1306.
18. Oshimura M, Kugoh H, Koi M, Shimizu M, Yamada H, Satoh H, Barrett C. Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell lines. J Cell Biochem 1990;42:135-142.
19. Koi M, Shimizu M, Morita H, Yamada H, Oshimura M. Construction of mouse A9 clones containing a single human chromosome tagged with neomycin-resistance gene via microcell fusion. Jpn J Cancer Res 1989;80:413-418.
20. Ichikawa T, Kyprianou N, Isaacs JT. Genetic instability and the acquisition of metastatic ability by rat mammary cancer cells following v-H-ras oncogene transfection. Cancer Res 1990;50: 6349-6357.
21. Treiger B, Isaacs JT. Expression of a transfected v-Harvey-ras oncogene in a Dunning rat prostatic adenocarcinoma and the development of high metastatic ability. J Urol 1988;140:1580-1586.
22. Ashworth LK, Batzer MA, Brandriff B, Branscomb E, De Jong P, Garcia E, Garnes JA, Gordon LA, Lamerdin JE, Lennon G, Mohrenweiser H, Olsen AS, Slezak T, Carrano AV. An integrated metric physical map of human chromosome 19. Nat Genet 1995; 11:422-427 (data will be updated quarterly on the Internet: http://www-bio.llnl.gov/bbrp/genome/genome.html).
23. Hudson TJ, Engelstein M, Lee MK, Ho EC, Rubenfield MJ, Adams CP, Housman DE, Dracopoli NC. Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms. Genomics 1992;13:622-629.
24. Isaacs JT, Isaacs WB, Feitz WFJ, Scheres J. Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate 1986;9:261-281.
25. Gao AC, Isaacs JT. Expression of homeobox gene-GBX2 in human prostate cancer cells. Prostate 1996;29:395-398.
26. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988;52:925-933.
27. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cecellion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis E, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707-710.
28. Ferrandon D, Elphick L, Nusslein-Volhard C, Johnston DS. Staufen protein associates with the 3′UTR of bicoid mRNA to form particles that move in a microtubule-dependent manner. Cell 1994;79:1221-1232.
29. Ewing CM, Ru N, Morton RA, Robinson RC, Wheelock MJ, Johnson KR, Barrett JC, Isaacs WB. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: Correlation with re-expression of a-catenin and restoration of E-cadherin function. Cancer Res 1995;55:4813-4817.
30. Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lathrop GM, Chabriat H, Mas JL, Cabanis EA, Baudrimont M, Maciazek J, Bach MA, Bousser MG. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 1993;3:256-259.
31. Thompson FH, Nelson MA, Trent JM, Guan XY, Liu Y, Yang JM, Emerson J, Adair L, Wymer J, Balfour C, Massey K, Weinstein R, Alberts DS, Taetle R. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. Cancer Genet Cytogenet 1996;87:55-62.
32. Madsen P, Rasmussen HH, Flint T, Gromov P, Kruse TA, Honore B, Vorum H, Celis JE. Cloning, expression, and chromosome mapping of human galectin-7. J Biol Chem 1995;270:5823-5829.
33. Mitelman F. "Catalog of Chromosome Aberrations in Cancer," 5th ed. New York: Wiley-Liss; 1994.